Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [847]

A reproducibility study in pulmonary adenocarcinomas supports a revised...

Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands

A reproducibility study in pulmonary adenocarcinomas supports a revised classification ( Dr Erik Thunnissen - VU University Medical Center, Amsterdam, The Netherlands )

OncoAlert Round Up for September 1-7, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 1-7, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Part 6: Which different PARP inhibitors are available

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 6: Which different PARP inhibitors are available ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Part 7: Similarities and Differences

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 7: Similarities and Differences ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Part 8: How PARP inhibitors are being used now

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 8: How PARP inhibitors are being used now ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Part 9: What PARP inhibitors mean for the future and what to look out for

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK

Part 9: What PARP inhibitors mean for the future and what to look out for ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )

Update from ASCO Breakthrough Asia Conference 2023

Dr Roselle de Guzman - Manila Central University-FDTMF Hospital, Manila...

Update from ASCO Breakthrough Asia Conference 2023 ( Dr Roselle de Guzman - Manila Central University-FDTMF Hospital, Manila, Philippines )

The impact of SEABCS 2023

Dr Heather White - Executive Director, TogetHER for Health

The impact of SEABCS 2023 ( Dr Heather White - Executive Director, TogetHER for Health )

OncoAlert Round Up for August 18th - 24th, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for August 18th - 24th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours

Dr Linda Malkas - City of Hope, Duarte, USA

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours ( Dr Linda Malkas - City of Hope, Duarte, USA )

Potential benefit to response rates from trastuzumab added to perioperative...

Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of...

Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC ( Dr Anna Wagner - The University of Lausanne, Lausanne, Switzerland, Co-chair of the EORTC Gastric Cancer Task Force )

Lenvatinib plus pembrolizumab versus standard of care for previously treated...

Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer ( Dr Akihito Kawazoe - National Cancer Center Hospital East, Kashiwa, Japan )

More from ecancer